We have investigated the mechanisms that bring about the termination of mitogen-activated protein kinase (MAP kinase) activation in response to UTP in EAhy 926 endothelial cells. UTP-stimulated MAP kinase activity was transient, returning to basal values by 60 min. At this time MAP kinase activation was desensitized ; re-application of UTP did not further activate MAP kinase, full re-activation of MAP kinase being only apparent after a 1-2 h wash period. However, activation of MAP kinase by UTP could be sustained beyond 60 min by preincubation of the cells with the protein synthesis inhibitor cycloheximide. UTP also stimulated expression of MAP kinase phosphatase-1 and this was abolished after pretreatment with cycloheximide. Pretreatment of cells with forskolin abolished the
INTRODUCTION
A major signalling pathway believed to play an intimate role in the regulation of cell growth and division in response to both growth factors and G-protein-coupled receptors involves the activation of intracellular enzymes by phosphorylation on tyrosine residues [1] . One family of enzymes activated in this manner are the mitogen-activated protein kinases (MAP kinases) [2, 3] . In response to growth factors such as platelet-derived growth factor, activation of MAP kinase is primarily mediated through association of mSos\Grb2 with the plasma-membrane-bound growth factor receptor, activation of p21 ras , subsequent activation of c-Raf-1 and activation of the upstream activator of MAP kinase, MAP kinase kinase (MEK) [4] . Agonists that act through G-protein-coupled receptors may utilize both Rasdependent and independent cascades to activate MAP kinase, the latter pathway involving the protein kinase C-mediated activation of c-Raf-1 or possibly MEK kinase [5] [6] [7] [8] [9] . MAP kinase is believed to play a role in the regulation of mitogenesis by phosphorylation of a number of intracellular proteins and enzymes. These include ribosomal S6 kinase ( p90 S'k ), cytosolic phospholipase A # , the phosphorylation of oncogenes such as c-jun and stimulation of glucose transport [10] [11] [12] [13] .
Despite these observations, the role of MAP kinase in the activation of DNA synthesis in response to G-protein-coupled receptor agonists remains controversial. An important feature for such agonists is thought to be the kinetics of MAP kinase activation [14] . Transient activation of MAP kinase is observed for a number of agonists such as angiotensin II and vasopressin, and these agonists do not possess mitogenic activity [15, 16] . In contrast, the phospholipid lysophosphatidic acid (LPA) and Abbreviations used : DMEM, Dulbecco's modified Eagle's medium ; HAT, supplement containing hypoxanthine, aminopterin and thymidine ; HRP, horseradish peroxidase ; IBMX, 3-isobutyl-1-methylxanthine ; MAP, mitogen-activated protein ; ERK, extracellular-signal-related protein kinase ; MEK, MAP kinase kinase or ERK kinase ; EGF, epidermal growth factor ; PMA, phorbol 12-myristate 13-acetate ; MKP-1, MAP kinase phosphatase-1 ; ECL, enhanced chemiluminescent ; DTT, dithiothreitol.
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initial activation of MAP kinase kinase or c-Raf-1 by UTP, but only affected MAP kinase activity during prolonged stimulation. The effect of forskolin on prolonged MAP kinase activation was also prevented by cycloheximide. These results suggest that the termination of MAP kinase activity in response to UTP involves a number of interacting mechanisms including receptor desensitization and the induction of a phosphatase. However, several pieces of evidence do not support a major role for MAP kinase phosphatase-1 in termination of the MAP kinase signal. Raising intracellular cyclic AMP may also be involved but only after an initial protein-synthesis step and by a mechanism that does not involve the inactivation of c-Raf-1 or MAP kinase kinase.
thrombin generate a sustained MAP kinase signal and both are potent mitogens for a number of cell types in culture [7, 8, 14, 17, 18] . Thus the efficacy of these G-protein-coupled agonists as mitogens may be regulated by the mechanisms that lead to the rapid termination of the MAP kinase response. Recently two specific MAP kinase phosphatases have been identified [19] [20] [21] [22] [23] [24] . MAP kinase phosphatase-1 (MKP-1) specifically dephosphorylates and inactivates MAP kinase after serum stimulation in fibroblasts, but has been shown to play no role in MAP kinase inactivation in several other cell types [20, 25] . This study was designed to determine the importance of receptor desensitization [26] and induction of MAP kinase phosphatases such as MKP-1 [19] [20] [21] [22] [23] [24] [25] in the termination of the MAP kinase signal in EAhy 926 endothelial cells. Our results show that desensitization of the MAP kinase cascade is a feature of the UTP-mediated response and plays a role in the regulation of MAP kinase activity together with the induction of a phosphatase, but that this is unlikely to be MKP-1. In addition, we show that agonist-mediated generation of intracellular cyclic AMP may play a role in termination of the MAP kinase signal through a distinct mechanism which does not involve inhibition of c-Raf-1 or MEK but is protein-synthesisdependent.
MATERIALS AND METHODS

Materials
All materials were of the highest commercial grades available. The BIOTRAK2 MAP kinase assay kits, [γ-$#P]ATP (300 Ci\ mmol), secondary antibodies and enhanced chemiluminescent (ECL) detection reagents were purchased from Amersham International (Amersham, Bucks., U.K.). All anti-phosphotyrosine, (anti-MAP kinase) and anti-MEK antibodies were obtained from Affiniti Research Products Ltd. (Exeter, Devon, U.K.), and c-Raf-1 and MKP-1 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Cell culture equipment and serum were from Gibco (Paisley, Scotland, U.K.).
Cell culture
The human-derived EAhy 926 endothelial cell line [27] was maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10 % foetal calf serum, hypoxanthine\aminopterin\ thymidine (HAT supplement), 27 mg\ml glutamine and penicillin\streptomycin (250 units\ml and 25 mg\ml respectively) at 37 mC in a humidified atmosphere of air\CO # (19 : 1, v\v). Experiments were performed in cells grown to confluency on 6 cm# plates or in 80 cm# flasks made quiescent by serum deprivation for 48 h.
Cell stimulation
Cells were washed in serum-free DMEM containing HAT supplement and antibiotics as above 30 min before the experiment, pretreated as required, then stimulated with agonist or vehicle for the appropriate times at 37 mC in a humidified atmosphere of air\CO # (19 : 1, v\v). The reaction was terminated by rapid aspiration followed by washing in ice-cold 20 mM Hepes buffer, pH 7.4, containing 150 mM NaCl, 50 mM NaF, 10 mM Na % P # O ( , 4 mM EDTA, 2 mM EGTA and 2 mM Na $ VO % . After the final aspiration, 0.5 ml of SDS sample buffer (70 mC) was added and the sample passed repeatedly through a 21G needle. The samples were boiled for 5 min and then stored at k80 mC until analysis.
Western blotting
Aliquots of each sample (30-50 µg of protein) were subjected to SDS\PAGE (10 % gel) and then transblotted on to nitrocellulose. The nitrocellulose blots were blocked for non-specific binding for 3 h in 50 mM Tris\HCl buffer, pH 7.4, containing 150 mM NaCl, 0.2 % (v\v) Tween (NaTT) and 3 % BSA, then incubated in NaTT containing 0.2 % BSA and 200 ng\ml rabbit polyclonal IgG anti-phosphotyrosine antibody overnight. The blots were rinsed in NaTT buffer, washed for 90 min (six changes of NaTT) and then incubated for 60 min in buffer containing 0.2 % BSA and a donkey anti-rabbit IgG antibody conjugated to horseradish peroxidase (HRP) (1 : 10 000 dilution). The blots were then washed for 120 min (eight changes of NaTT) and developed using ECL detection (Amersham). The blotting procedure was assessed for specificity for phosphotyrosine, appropriate antibody dilution and linearity with increasing protein concentrations (results not shown). For analysis of the activation of MAP kinase, 10 ng\ml of the mouse monoclonal anti-(MAP kinase) antibody (MK12) and a donkey anti-mouse IgG antibody conjugated to HRP (1 : 10 000) were employed.
In vitro MAP kinase activity
Cells in individual 80 cm# flasks were made quiescent for 48 h and stimulated with 100 µM UTP for appropriate times. The reaction was terminated by addition of 5 ml of ice-cold 150 mM NaCl. Flasks were washed with a further 5 ml of NaCl and cells pelleted at 1000 g for 5 min. The pellet was transferred to Eppendorf tubes and dispersed into 10 mM Tris\HCl buffer, pH 7.4, containing 150 mM NaCl, 2 mM EGTA, 2 mM dithiothreitol (DTT), 1 mM Na $ VO % , 1 mM PMSF, 10 µg\ml leupeptin and 10 µg\ml aprotinin by repeated passage through a 25G needle. Samples were then centrifuged for 15 min at 2500 g and the supernatants (70-90 µg of protein) assayed for MAP kinase activity using the epidermal growth factor (EGF) receptor peptide as substrate (BIOTRAK MAP kinase assay kit).
c-Raf-1 kinase activity
Quiescent cells in 80 cm# flasks were incubated with agonist, and the reaction was terminated with ice-cold saline containing EDTA. Cells were collected by centrifugation (2 min ; 500 g) and solubilized in 20 mM Tris\HCl, pH 7.9, containing 137 mM NaCl, 5 mM EDTA, 10 mM NaF, 10 mM Na % P # O ( , 1 mM Na $ VO % , 100 µM PMSF, 10 µg\ml aprotinin, 1 % (v\v) Triton X-100 and 10 % (v\v) glycerol. The supernatants were precleared by centrifugation in a Microfuge for 10 min at 10 000 g, and equal portions (250-300 µg) incubated with 2 µg of a c-Raf-1 polyclonal antibody for 4 h at 4 mC with gentle rotation. The lysates were then incubated for a further 60 min with Protein A-Sepharose. The immunoprecipitates were collected, washed twice in solubilization buffer, twice in buffer without detergents and twice in 25 mM Hepes buffer, pH 7.4, containing 25 mM glycerophosphate, 1 mM DTT, 15 mM MgCl # and 5 mM McCl # . Immunoprecipitates were then incubated in the same buffer containing 50 µM ATP, 10 µCi of [γ-$#P]ATP and 200 ng of inactive MEK (MEK B). The reaction was terminated and samples subjected to SDS\PAGE (10 % gel). The gel was fixed, dried and exposed to film overnight at k80 mC.
Expression and purification of histidine-tagged MAP kinase
Active and inactive Xenopus pp42 MAP kinase was synthesized and purified as a histidine-tagged glutathione S-transferase fusion protein in the Escherichia coli strain BL21(ED3)pLysS after transfection with the pRSETB plasmid containing cDNA inserts as previously defined [28] . The protein was purified from the bacterial cell lysates using a Ni-nitro-triacetic acid-Sepharose matrix.
MEK immunoprecipitation and assay
Quiescent cells in 10 cm-diameter Petri dishes (Corning) were stimulated with agonist, washed twice in PBS, then solubilized in 250 µl of 10 mM Tris\HCl buffer, pH 7.5, containing 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 2 mM Na $ VO % (immunoprecipitation buffer), 1 % (v\v) Triton X-100 and 0.5 % (v\v) Nonidet P40. They were then incubated with 1 µg\ml anti-(MEK 1,2) antibody (Affiniti) followed by pansorbin for 90 min. Immunoprecipitates were recovered, washed and then incubated in a 25 mM Hepes buffer, pH 7.2, containing 25 mM β-glycerophosphate, 15 mM MgCl # , 5 mM MnCl # , 1 mM DTT, [γ-$#P]ATP (5 µCi ; 50 µM), 1 µg of either purified wild-type or inactive MAP kinase and 200 mM peptide pseudosubstrate EGF receptor peptide as above for 30 min. Aliquots of the reaction mixture were assayed for peptide phosphorylation as outlined above or samples subjected to SDS\PAGE (10 % gel) and gels exposed to autoradiographic film overnight.
Immunoprecipitation of MKP-1
Quiescent cells in 10 cm diameter dishes (Corning) were incubated with agonist for 60 min, then washed twice in PBS and solubilized in 500 µl of immunoprecipitation buffer containing 1 % (v\v) Triton X-100 and 0.5 % (v\v) Nonidet P40. Cell lysates were precleared and incubated with 1.5 µg of anti-MKP-1 antibody for 2 h. MKP-1 immunoprecipitates were recovered after incubation for 90 min with pansorbin and samples were resuspended in SDS sample buffer before Western blotting using 50 ng\ml anti-MKP-1 antibody.
Cyclic AMP assay
Cyclic AMP levels were assessed using a commercially available kit (Amersham International) as previously described [29] .
RESULTS
Stimulation of MAP kinase in EAhy 926 cells by UTP
In the endothelial cell line EAhy 926, the nucleotide UTP stimulated tyrosine phosphorylation of the pp42 isoform of MAP kinase in a concentration-dependent manner. Maximal activation occurred within 2 min and levels returned to basal by 60 min as shown in Figure 1(a) . The time course of tyrosine phosphorylation was closely matched by the shift in mobility of MAP kinase when the phosphotyrosine blots were reprobed with a specific MAP kinase antibody (MK12) as shown in Figure 1(b) . MAP kinase activation, as assessed by in itro phosphorylation of the specific EGF receptor peptide, also followed a similar time course (Figure 1c) .
Desensitization of the MAP kinase response to UTP
It has previously been shown that mitogenic agonists such as LPA can restimulate MAP kinase, thereby providing a rationale for the mitogenic effect of this phospholipid [30] . One feature of many purinergic responses is desensitization and this is known to occur at the level of second messengers in some cases [26, 31] . We
Figure 1 Time course of UTP-stimulated MAP kinase activation in EAhy 926 endothelial cells
In (a) cells were incubated with 100 µM UTP (U) for the times indicated (min) and assayed for phosphotyrosine content. pp42 MAP kinase is shown by the arrow. The blots were reprobed for MAP kinase content (b). C represents unstimulated cells. Each blot is representative of at least three others.
Figure 2 Desensitization and resensitization of UTP-stimulated tyrosine phosphorylation of pp42 MAP kinase in EAhy 926 endothelial cells
Cells were pretreated with UTP (100 µM) for 60 min before further incubations with either vehicle (C) or UTP (U) were carried out. Tyrosine phosphorylation and MAP kinase content were assessed as described in the Materials and methods section. In (a) cells were washed with serum-free DMEM and then rechallenged with UTP for the indicated times after a 2 h period. (b) shows the results when no wash protocol was carried out after the 60 min preincubation with UTP. Numbers represent time of rechallenge with UTP and the arrowhead represents the tyrosine-phosphorylated band corresponding to pp42 MAP kinase. Each blot is representative of at least three independent experiments. Vehicle used was serum-free DMEM.
Table 1 UTP-stimulated MAP kinase desensitization and restimulation after removal of agonist
EAhy 926 endothelial cells were stimulated with UTP for 60 min and then rechallenged with UTP after 1 or 2 h periods. At the 60 min time point in some experiments, agonist was washed off (wash), and this was compared with the effect after agonist was left in contact with the cells for the entire incubation period (no wash). Rechallenge with UTP was for 5 min. MAP kinase activity was measured as described in the Materials and methods section. sought to determine if restimulation of MAP kinase could be achieved in response to UTP or if desensitization was a feature of the response in this endothelial cell line. After an initial 60 min stimulation with UTP, further activation of MAP kinase was not observed on re-addition of agonist when MAP kinase activation was assessed by either Western blotting (Figure 2 ) or in itro kinase assay (Table 1 ). This effect was apparent for between 1 and 2 h. However, rechallenge with UTP did elicit a response after a wash period of 1-2 h. Full activation of MAP kinase was only observed after a 2 h wash period, although a proportion of the stimulation was recovered after 60 min. Stimulation of MAP kinase with phorbol 12-myristate 13-acetate (PMA) (100 nM ; 10 min) under these conditions produced maximal activation of MAP kinase. In addition, MAP kinase activation in response to the G-protein-coupled receptor agonist LPA (10 µM ; 2 min) was also still observed to a similar magnitude as that seen in nonpretreated cells (Figure 3 ). These results indicate that the upstream pathway for MAP kinase can still be fully activated under conditions in which UTP-mediated desensitization is apparent.
Effect of cycloheximide on UTP-stimulated MAP kinase activation in EAhy 926 cells
In order to determine if desensitization was the only mechanism responsible for MAP kinase inactivation, experiments were conducted on cells pretreated with cycloheximide which prevents new protein synthesis. Figure 4 (a) shows that cycloheximide alone slightly increased the basal level of tyrosine phosphorylation and activation of MAP kinase. However, preincubation for 60 min with 100 µg\ml cycloheximide before UTP stimulation both potentiated the magnitude of the MAP kinase response and prolonged the signal, such that after 2 h, full activation of MAP kinase was still observed. However, after removal of the agonist after 30 min stimulation, when MAP kinase activity was assessed at 60 min, a time point when MAP kinase is fully desensitized, no MAP kinase activation was observed (Figure 4b ) demonstrating that preventing protein synthesis is not sufficient to maintain the MAP kinase response to UTP but an additional event is required.
Effect of forskolin on UTP-mediated stimulation of c-Raf-1, MEK and MAP kinase activation
Increasing cyclic AMP is known to phosphorylate and inactivate c-Raf-1 in several cell types including fibroblasts [32, 33] . We therefore investigated whether forskolin pretreatment inhibited the MAP kinase signal in response to UTP. Pretreatment of
Figure 4 Effect of cycloheximide on the time course of UTP-mediated tyrosine phosphorylation and activation of MAP kinase in EAhy 926 endothelial cells
In (a) cells were incubated with 100 µM UTP (U) for the times indicated in the presence or absence of 100 µg/ml cycloheximide (CX). Cell lysates were assayed for phosphotyrosine and MAP kinase content as outlined in the Materials and methods section. The arrow represents the tyrosine-phorphorylated band corresponding to pp42 MAP kinase. In (b) the cells pretreated with cycloheximide were incubated for the times indicated with UTP then washed with serumfree DMEM (*), left until a total time of 60 min had elapsed and MAP kinase content assessed as described in the Materials and methods section. C represents unstimulated cells. Each blot is representative of at least three others. EAhy 926 endothelial cells with forskolin (10 µM) in the presence of IBMX (100 µM) for 15 min stimulated a small, approximately 2-fold increase in intracellular cyclic AMP and this was potentiated by UTP (Table 2) . Under these conditions, the initial MAP
Figure 5 Effect of forskolin on UTP-mediated activation of c-Raf-1, and MEK activity in EAhy 926 endothelial cells
Cells were incubated with vehicle or 10 µM forskolin in the presence of IBMX (F) for 15 min before stimulation with 100 µM UTP (U) for various times. C represents unstimulated cells. In (a) cell lysates were assessed for phosphotyrosine and MAP kinase content as described in the Materials and methods section. The arrow represents the tyrosine-phosphorylated band corresponding to pp42 MAP kinase. In (b) cells were assayed for Raf-1 activity (the position of MEK B is indicated with an arrowhead). In (c) MEK activity was assessed by phosphorylation of MAP kinase as described in the Materials and methods section. Each blot is representative of at least three experiments.
kinase signal in response to UTP was unchanged (Figure 5a ) although UTP-mediated c-Raf-1 kinase activity at 2 min was abolished (Figure 5b ). MEK activity, as assessed by in itro kinase assay after MEK immunoprecipitation, was constitutively high in resting cells (3.2 pmol of P i \min per mg of protein). MAP kinase was activated by MEK in itro, but only to a small extent (4.7 pmol of P i \min per mg of protein). Pretreatment with forskolin abolished MEK-induced MAP kinase activation (3.9 pmol of P i \min per mg of protein ; and Figure 5c ). Although forskolin pretreatment did not affect the initial activation of MAP kinase by UTP, this treatment enhanced the rate of termination of the MAP kinase signal in response to UTP (Figures 5a and 6) . Pretreatment of the cells with cycloheximide not only prolonged UTP-induced activation of MAP kinase, but also prevented any effect of forskolin on the termination of the response ( Figure 6 ).
Figure 6 Effect of cycloheximide on forskolin-mediated inhibition of UTP-stimulated tyrosine phosphorylation and activation of MAP kinase in EAhy 926 endothelial cells
Cells were preincubated with or without 10 µM forskolin plus IBMX (F) in the presence or absence of 100 µg/ml cycloheximide (CX) before being stimulated with 100 µM UTP (U) for the times indicated. Phosphotyrosine (a) and MAP kinase (b) content were assessed as outlined in the Materials and methods section. The arrow represents the tyrosine-phosphorylated band corresponding to pp42 MAP kinase. C represents unstimulated cells. Each blot is the representative of at least three others.
Induction of MKP-1
Incubation of cells with UTP for 60 min resulted in the appearance of a 40 kDa band which was identified by antibodies against a specific sequence of MKP-1. This band was identified as MKP-1 by both molecular mass and its induction after incubation with serum for 60 min as previously reported [19] ( Figure 7) . Treatment of the cells with forskolin (10 µM ; 60 min) in the presence of IBMX also induced expression of MKP-1 protein. This effect was not due to IBMX since IBMX alone did not induce this protein (Figure 7 ). The mitogenic phospholipid LPA, which gives a sustained MAP kinase signal in this cell type, was a poor inducer of MKP-1.
Figure 7 UTP-mediated induction of MKP-1 in EAhy 926 cells
Immunoprecipitates were prepared from cell lysates using an antibody against MKP-1. C, unstimulated cells ; F, cells pretreated with forskolin (10 µM) in the presence of IBMX ; L, LPAtreated cells (10 µM) ; U, UTP-treated cells (100 µM) ; S, serum-treated cells (10 %) ; I, IBMX treatment alone (100 µM). All cells were treated for 60 min.
DISCUSSION
Here we show that MAP kinase activation occurs in a time-and concentration-dependent manner in EAhy 926 endothelial cells in response to the nucleotide UTP ( Figure 1 ). This is likely to involve activation of a P #U purinoceptor [34] (A. Graham, A. McLees, K. Malarkey, G. W. Gould and R. Plevin, unpublished work). This activation is transient, maximal activation occurring within 2 min and the signal returning to basal levels by 60 min. We have demonstrated that homologous desensitization of the MAP kinase response to UTP occurs, as evidenced by the fact that rechallenge with either ATP or UTP does not result in re-activation of the MAP kinase signal, even up to 3 h after initial stimulation with agonist ( Figure 2 ). This is not likely to be the result of loss of function of any of the intermediate pathways upstream of MAP kinase since the magnitude of MAP kinase activation in response to both phorbol ester and the mitogenic phospholipid LPA was unaffected under conditions where UTPmediated desensitization is manifest. This transient activation of MAP kinase by UTP is in contrast with the results obtained in a previous study where LPA-mediated restimulation of MAP kinase occurs [30] . However, a number of studies have previously shown that receptor desensitization is a feature of P #U -purinoceptor-mediated responses in a number of cells types and is reflected at the level of second-messenger generation [26, 31] .
We found that after 60 min stimulation, during the period when MAP kinase activity is desensitized in response to UTP, termination of the MAP kinase response could be prevented by pretreatment of the cells with the protein synthesis inhibitor cycloheximide (Figure 4a ). This suggests that, although desensitization prevents continual activation of MAP kinase in response to repeated stimulation, de no o protein synthesis is required before termination of the initial MAP kinase signal occurs. Recently, several phosphatases that are induced after stimulation by mitogens have been identified which dephosphorylate and thus inactivate MAP kinase [19] [20] [21] [22] [23] [24] . We speculated that our observation of a sustained MAP kinase signal obtained after preincubation with cycloheximide may be a result of prevention of induction of a specific MKP. In order to address this, we made use of an antiserum against the MKP-1 isoform to examine the level of expression of this phosphatase during desensitization. After incubation of the cells with UTP, we observed expression of a 40 kDa protein which was recognized by antibodies raised against a specific sequence of MKP-1. This protein was also present when the cells were treated with serum, a condition that has previously been shown to induce MKP-1 [19, 21] . Cycloheximide pretreatment led to total abrogation of expression of this protein (Figure 7 ) supporting the hypothesis that UTP plays a role in the termination of its own signal by inducing protein expression. However, under conditions where maximal MKP-1 induction in response to UTP was observed, activation of MAP kinase was still observed on addition of other agonists, such as LPA and phorbol ester. In addition, when cells were pretreated with cycloheximide to prevent MKP-1 induction, the prolonged MAP kinase signal was lost on removal of agonist after 30 min (Figure 4b ), a time point where cycloheximide was effective in prolonging the signal. Our interpretation of these observations is that activation of MAP kinase is still occurring at 30 min despite receptor desensitization and that the activation status of MAP kinase observed at any point in time results from a balance of phosphorylation and dephosphorylation caused by phosphatase activity. For MKP-1 to be the phosphatase involved, MAP kinase must be accessible to the phosphatase, and whether translocation of MAP kinase occurs in response to UTP has yet to be established. It is clear from these results that desensitization of the pathway upstream of MAP kinase must also be a key event in the termination of agonist-stimulated MAP kinase activity. These findings extend recent studies which showed that when MKP-1 induction was abolished in bovine pulmonary artery endothelial cells and in PC12 cells, there was no effect on the rapid termination of EGF-stimulated MAP kinase activity [20, 25] .
A number of recent studies have proposed that certain Gprotein-coupled agonists are able to terminate their own MAP kinase signal by a protein kinase C-dependent activation of adenylate cyclase [33] and a proposed subsequent phosphorylation of c-Raf-1 [33, [35] [36] [37] . We investigated whether this was the mechanism by which the UTP-induced termination of the MAP kinase response occurred. However, only weak and transient activation of both c-Raf-1 and MEK was observed within these cells in response to UTP and this does not correlate with either the kinetics or magnitude of the MAP kinase signal. Pretreatment of the cells with forskolin did not affect MAP kinase activation at 2 min, despite clear inhibition of the upstream activators, MEK and c-Raf-1 ( Figure 5 ). These results suggest that it is possible that MAP kinase activation in response to UTP may be occurring through a MEK-independent mechanism. Recently other authors have observed a similar dissociation of MAP kinase activation from the kinetics and magnitude of the classical upstream activators and have suggested that these results can be explained by compartmentalization of active MAP kinase allowing protection from inactivation [20] .
In contrast with these observations, forskolin pretreatment inhibited MAP kinase activity during prolonged stimulation with both UTP and, as outlined in a recent study, LPA [30] . Our evidence does not support a role for inactivation of c-Raf-1 as the mechanism by which this inhibition of MAP kinase activity occurs. In addition, we believe it is also unlikely to be a result of a time-dependent increase in cyclic AMP, as cyclic AMP concentration at 60 min was still only twice basal values after forskolin administration or four times basal values in the additional presence of UTP (Table 2 ). However, we have found that cycloheximide blocked the effect of forskolin on the later component of the MAP kinase signal, suggesting a role for protein induction in the forskolin response. Forskolin stimulated induction of MKP-1 ( Figure 7) ; however, prolonged forskolin pretreatment did not reduce the subsequent initial activation of MAP kinase by UTP (results not shown). The induction of MKP-1 by forskolin may indicate a regulatory role for protein kinase A in termination of MAP kinase, since the time at which forskolin is effective in enhancing termination of MAP kinase (30 min) would allow for MKP-1 to be induced in response to forskolin.
Previous studies that suggest a single induction or phosphorylation event have not considered the involvement of any potential additional mechanisms in such a receptor-mediated termination of the MAP kinase signal. Our observations suggest roles for receptor-mediated desensitization of the MAP kinase signal, together with induction and regulation of other proteins, in termination of the MAP kinase signal. In addition, there may be a role for a c-Raf-1\MEK-independent kinase pathway in generation and termination of MAP kinase activity in EAhy 926 cells. The multiple regulatory mechanisms which therefore participate in the termination of agonist-induced MAP kinase activity are likely to ensure that the kinetics of MAP kinase activation will be unique to each receptor\cell system studied.
